Cambridge Cancer Genomics (Ccg.Ai; Acquired By Dante Labs)

Cambridge Cancer Genomics (CCG. ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance.
Social Link - Twitter: https://twitter.com/CCGenomics
Social Link - Linkedin: http://www. linkedin.com/company /ccgenomics
Employee Count: 2
Keywords: information technology & services